According to a report by the New York Post on the 29th, according to a new medical study in the United States, the condition of severely ill patients with COVID-19 pneumonia is similar to the symptoms after a bite by a poisonous rattlesnake.
According to an analysis published in the Journal of Clinical Research, researchers including Stony Brook University on Long Island have discovered an enzyme in the COVID-19 virus. This enzyme can cause damage to the human body. Its mechanism is like rattlesnake venom. The same as the neurotoxin in.
Scientists at the State University of New York, the University of Arizona and Wake Forest University said that this enzyme can cause severe inflammation. Further research on this enzyme can better treat COVID-19 patients and save their lives.
According to the study, the sPLA2-II enzyme in the COVID-19 virus is similar to an active enzyme in rattlesnake venom. This active enzyme usually exists in healthy people, but at a low concentration, and has been considered for a long time. It plays a key role in humans' defense against bacterial infections.
But the senior author of the paper, Freud Chilton of the University of Arizona, said that when the same enzyme circulates in the body at high levels, it "tears" the cell membranes of vital organs.
"This research supports a new treatment goal to reduce the death rate of COVID-19 pneumonia." Dr. Maurizio Del Porta of Stony Brook University explained, "Because sPLA2-IIA inhibitors have been discovered, our Research supports the use of these inhibitors in patients with elevated sPLA2-IIA levels to reduce mortality."
Dr. Delporta’s research team collected stored plasma samples and analyzed the medical charts of 127 patients who were hospitalized at Stony Brook University Hospital from January to July 2020.
They also examined 154 patient samples collected from Stony Brook and Banner University Medical Center in Tucson from January to November 2020.
A researcher said: "Considering that the delta variant has led to an increase in the COVID-19 virus infection rate and hospitalization rate in the United States and around the world, our research is particularly relevant."
0 Comments